Irish sports science company Orecco has completed a $2 million fundraising round which will enable the company to further develop its product range and to expand in the US and Europe.
The investment has come from US Based True Ventures who previously scored with an early stage investment in Fitbit and have a wide portfolio of bets on companies involved in data and analytics.
“Leveraging machine learning in personalized digital health care is a great opportunity,” said True Ventures co-founder Phil Black. “Orreco is poised for rapid growth in the professional and amateur athlete markets thanks to Brian and his team of veteran sports and data scientists.”
Read more about the first Orreco Sports Science Summit in Galway last October
“We are delighted to join the True portfolio given their proven track record in identifying market-leading solutions, particularly in our space,” said Dr. Brian Moore. “The investment will allow us to grow our U.S. presence, further develop our product suite and support ongoing investment in research and development. We will actively recruit additional world-class data and sports scientists, and software engineers.”
Orreco is the first high-performance sport company in the world to partner with IBM Watson, the cognitive computing platform. The Galway based company’s actionable data and expertise is fed into Watson to help coaches and professional athletes make key decisions based on the latest scientific research and personalized solutions for nutrition, sleep and training programs.
“This investment also moves us closer to the day when this expertise will be available to amateur athletes, helping us all to prepare for our next sporting event just like an Olympian or a pro-basketball player,” said Moore.
